MedTrace Logo

Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG

NCT03609723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2433

Last updated 2019-08-01

No results posted yet for this study

Summary

A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.

Conditions

  • Complication of Coronary Artery Bypass Graft
  • Complication of Extracorporeal Circulation

Interventions

PROCEDURE

CABG

CABG with application of a myocardial protection system (MPS ®) and using a minimal extracorporeal circulation system (MiECC) or CABG without use of a minimal extracorporeal circulation system (Off-pump coronary artery bypass grafting = OPCABG)

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Oliver Reuthebuch, PD MD · Klinik für Herzchirurgie, Universitätsspital Basel Spitalstrasse 21 4031 Basel

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-12
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03609723 on ClinicalTrials.gov